zintick

CareDx CDNA

CareDx, Inc. · Nasdaq · Services-Medical Laboratories

$87.41+22.22%close on Oct. 30, 2026 · volume 3.6M · Yahoo Finance

Price, last 49 sessions

$50.00$60.00$70.00$80.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 30, 2026 · high $87.41 · low $47.50 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Aug. 5, 2026George Bickerstaff
director
Sold20,000$46.29$925,700
Aug. 5, 2026Jeffrey Adam Novack
Secretary and General Counsel
Sold
10b5-1 plan
2,688$46.26
$46.15-$46.75
$124,349
Aug. 4, 2026Christine Cournoyer
director
Sold
10b5-1 plan
16,000$46.94$750,973
Aug. 4, 2026Michael Goldberg
director
Sold44,700$47.06$2.10 million

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 21 →
  • 10-QOct. 29, 2026, 4:04 p.m. ETView on SEC.gov
  • 8-KOct. 29, 2026, 4:02 p.m. ETView on SEC.gov

    Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedCareDx Q3 2026 Revenue Rises 39% to $139.4 Million, Beats $122.0 Million Consensus; Non-GAAP EPS $0.70 vs $0.26 Expected; 2026 Revenue Guidance Raised to $520-530 Million

  • 4Oct. 5, 2026, 6:46 p.m. ETView on SEC.gov
  • 4Oct. 5, 2026, 6:49 p.m. ETView on SEC.gov
  • 4Oct. 5, 2026, 6:47 p.m. ETView on SEC.gov
  • 4Oct. 5, 2026, 6:47 p.m. ETView on SEC.gov
  • 4Oct. 5, 2026, 5:35 p.m. ETView on SEC.gov
  • 8-K/ASept. 16, 2026, 4:06 p.m. ETView on SEC.gov

    Completion of acquisition or disposition of assets · Financial statements and exhibits